These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1819007)

  • 1. Metabolic effects of enalapril and nifedipine in diabetic hypertensives.
    Andronico G; Angileri G; Piazza G; Cerasola G
    J Hypertens Suppl; 1991 Dec; 9(6):S408-9. PubMed ID: 1819007
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM.
    Chan JC; Yeung VT; Leung DH; Tomlinson B; Nicholls MG; Cockram CS
    Diabetes Care; 1994 Aug; 17(8):859-62. PubMed ID: 7956631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril with and without hydrochlorothiazide in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Bilo HJ; Westerman RF; Nicolaas-Merkus AM; Donker AJ
    Diabetes Res; 1988 Sep; 9(1):21-5. PubMed ID: 2853659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine vs. enalapril in treatment of hypertensive patients with glucose intolerance.
    Andronico G; Piazza G; Mangano MT; Mule G; Carone MB; Cerasola G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S52-4. PubMed ID: 1725004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics.
    Baba S;
    Diabetes Res Clin Pract; 2001 Dec; 54(3):191-201. PubMed ID: 11689274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy].
    Andronico G; Carone MB; Mulè G; Mangano MT; Cerasola G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1161-4. PubMed ID: 2100527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
    Chellingsworth MC; Kendall MJ; Wright AD; Singh BM; Pasi J
    J Hum Hypertens; 1989 Feb; 3(1):35-9. PubMed ID: 2657057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.
    Chan JC; Cockram CS; Nicholls MG; Cheung CK; Swaminathan R
    BMJ; 1992 Oct; 305(6860):981-5. PubMed ID: 1458144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protocol-driven care versus usual outpatient clinic care on survival rates in patients with type 2 diabetes.
    So WY; Tong PC; Ko GT; Leung WY; Chow CC; Yeung VT; Chan WB; Critchley JA; Cockram CS; Chan JC
    Am J Manag Care; 2003 Sep; 9(9):606-15. PubMed ID: 14527106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isradipine and nifedipine retard in hypertensive patients with type II diabetes mellitus.
    Gomis R; Vidal J; Novials A; Coves MJ
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):102S-103S. PubMed ID: 8466715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G; Carraro A; Brocco E; Adezati L; Andreani D; Bompiani G; Brunetti P; Fedele D; Giorgino R; Giustina G
    Acta Diabetol; 1995 Oct; 32(3):203-8. PubMed ID: 8590792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Diabetes Care; 1991 Oct; 14(10):911-4. PubMed ID: 1773691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
    Sano T; Kawamura T; Matsumae H; Sasaki H; Nakayama M; Hara T; Matsuo S; Hotta N; Sakamoto N
    Diabetes Care; 1994 May; 17(5):420-4. PubMed ID: 8062609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
    Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of enalapril with and without hydrochlorothiazide on insulin sensitivity and other metabolic abnormalities of hypertensive patients with NIDDM.
    Shamiss A; Carroll J; Peleg E; Grossman E; Rosenthal T
    Am J Hypertens; 1995 Mar; 8(3):276-81. PubMed ID: 7794577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic effects of berlipril-5 in patients with non-insulin dependent diabetes mellitus and arterial hypertension].
    Ametov AS; Gubina EV
    Ter Arkh; 1999; 71(10):22-5. PubMed ID: 10612168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients.
    Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG
    Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blocker drugs and diabetic control.
    Collins WC; Cullen MJ; Feely J
    Clin Pharmacol Ther; 1987 Oct; 42(4):420-3. PubMed ID: 3311549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.